Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on romiplostim for chemotherapy-induced thrombocytopenia in adults with gastrointestinal, pancreatic, or colorectal cancer; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Amgen | Conditions: Chemotherapy-induced Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2026-02-11